Close Menu

This story has been updated from a previous version to include comments from Quidel's earnings call.

NEW YORK (GenomeWeb) –  Quidel reported after the close of the market on Wednesday that its second quarter revenues dropped 2 percent year over year, driven by a decline in influenza-related testing.

For the three months ended June 30, the company reported that revenues dropped to $38.3 million from $39.1 million in Q2 2016, and missed the average analysts' estimate of $41.8 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.